Abstract
We report an acid-reversible linker for triggered release of Bis-T-23, an experimental small molecule drug for kidney disease treatment that restores podocyte morphology during disease. Bis-T-23 contains catechols, which form an acid-reversible, covalent boronate ester bond with boronic acids. We synthesized phenylboronic acid-containing polymers using reversible addition-fragmentation chain transfer polymerization that were able to directly load and solubilize Bis-T-23. Because of the reversibility of the boronic ester bond, drug was released in its native form in a pH-dependent manner. The polymers rapidly trafficked into acidic compartments and did not exhibit cytotoxicity, and polymer-drug conjugates successfully delivered Bis-T-23 into cultured podocytes.
| Original language | English |
|---|---|
| Pages (from-to) | 3968-3973 |
| Number of pages | 6 |
| Journal | ACS Biomaterials Science and Engineering |
| Volume | 4 |
| Issue number | 12 |
| DOIs | |
| State | Published - 10 Dec 2018 |
Keywords
- Bis-T-23
- boronic acid
- drug delivery
- polymers
- triggered release
Fingerprint
Dive into the research topics of 'Boronic Acid Copolymers for Direct Loading and Acid-Triggered Release of Bis-T-23 in Cultured Podocytes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver